Aratana Therapeutics Inc. Email Format

Pharmaceutical ManufacturingKansas, United States11-50 Employees

Aratana Therapeutics is a veterinary-focused pharmaceutical company that develops and commercializes medicines for dogs and cats. The company emphasizes therapies with differentiated profiles intended to address practical needs in companion-animal care and aims to support veterinarians while collaborating with other health companies, including those in human and animal health. Its FDA-approved offerings include a prostaglandin receptor antagonist that targets the EP4 receptor to alleviate osteoarthritis pain and inflammation in dogs, a selective ghrelin receptor agonist that stimulates appetite in dogs, and a long-acting local anesthetic that provides up to 72 hours of postoperative pain relief in dogs and cats. 

Headquartered in Leawood, Kansas, the company operates in the pharmaceutical manufacturing sector with a focus on pet therapeutics and maintains a relatively small team. In 2022, Aratana disclosed a collaboration to develop and commercialize a novel stem cell therapy for dogs, representing a recent advance in its research efforts.

Get verified Aratana Therapeutics Inc. emails free

Company overview Employee directory